122 related articles for article (PubMed ID: 34424670)
21. Characterization and preliminary evaluation of ester-modified technetium-99m SNS/S mixed ligand complexes as potential brain perfusion agents.
Tsoukalas C; Papadopoulos MS; Maina T; Pirmettis IC; Nock BA; Raptopoulou C; Terzis A; Chiotellis E
Nucl Med Biol; 1999 Apr; 26(3):297-304. PubMed ID: 10363801
[TBL] [Abstract][Full Text] [Related]
22. Clickable, hydrophilic ligand for fac-[M(I)(CO)3](+) (M = Re/(99m)Tc) applied in an S-functionalized α-MSH peptide.
Kasten BB; Ma X; Liu H; Hayes TR; Barnes CL; Qi S; Cheng K; Bottorff SC; Slocumb WS; Wang J; Cheng Z; Benny PD
Bioconjug Chem; 2014 Mar; 25(3):579-92. PubMed ID: 24568284
[TBL] [Abstract][Full Text] [Related]
23. Rhenium(i) complexes of N-heterocyclic carbene ligands that bind to amyloid plaques of Alzheimer's disease.
Chan CY; Noor A; McLean CA; Donnelly PS; Barnard PJ
Chem Commun (Camb); 2017 Feb; 53(15):2311-2314. PubMed ID: 28111677
[TBL] [Abstract][Full Text] [Related]
24. Structure-Activity Relationship Study of Heterocyclic Phenylethenyl and Pyridinylethenyl Derivatives as Tau-Imaging Agents That Selectively Detect Neurofibrillary Tangles in Alzheimer's Disease Brains.
Matsumura K; Ono M; Kitada A; Watanabe H; Yoshimura M; Iikuni S; Kimura H; Okamoto Y; Ihara M; Saji H
J Med Chem; 2015 Sep; 58(18):7241-57. PubMed ID: 26327138
[TBL] [Abstract][Full Text] [Related]
25. Development of novel mixed-ligand oxotechnetium [SNS/S] complexes as potential 5-HT1A receptor imaging agents.
Papagiannopoulou D; Pirmettis I; Maina T; Pelecanou M; Nikolopoulou A; Chiotellis E; Raptopoulou CP; Vlahos AT; Terzis A; Papadopoulos M; Chiotellis E
J Biol Inorg Chem; 2001 Mar; 6(3):256-65. PubMed ID: 11315561
[TBL] [Abstract][Full Text] [Related]
26. Development of novel 123I-labeled pyridyl benzofuran derivatives for SPECT imaging of β-amyloid plaques in Alzheimer's disease.
Ono M; Cheng Y; Kimura H; Watanabe H; Matsumura K; Yoshimura M; Iikuni S; Okamoto Y; Ihara M; Takahashi R; Saji H
PLoS One; 2013; 8(9):e74104. PubMed ID: 24058519
[TBL] [Abstract][Full Text] [Related]
27. Remarkable Brain Penetration of Cyclopentadienyl M(CO)
Sagnou M; Mavroidi B; Shegani A; Paravatou-Petsotas M; Raptopoulou C; Psycharis V; Pirmettis I; Papadopoulos MS; Pelecanou M
J Med Chem; 2019 Mar; 62(5):2638-2650. PubMed ID: 30768272
[TBL] [Abstract][Full Text] [Related]
28. Glucosamine conjugates bearing N,N,O-donors: potential imaging agents utilizing the [M(CO)3]+ core (M = Re, Tc).
Bowen ML; Lim NC; Ewart CB; Misri R; Ferreira CL; Häfeli U; Adam MJ; Orvig C
Dalton Trans; 2009 Nov; (42):9216-27. PubMed ID: 20449199
[TBL] [Abstract][Full Text] [Related]
29. Novel lipophilic amidate oxorhenium and oxotechnetium complexes as potential brain agents: synthesis, characterization and biological evaluation.
Papadopoulos M; Nock B; Maina T; Pirmettis I; Raptopoulou C; Tasiopoulos A; Troganis A; Kabanos T; Terzis A; Chiotellis E
J Biol Inorg Chem; 2001 Feb; 6(2):159-65. PubMed ID: 11293409
[TBL] [Abstract][Full Text] [Related]
30. Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy.
Polyakov V; Sharma V; Dahlheimer JL; Pica CM; Luker GD; Piwnica-Worms D
Bioconjug Chem; 2000; 11(6):762-71. PubMed ID: 11087323
[TBL] [Abstract][Full Text] [Related]
31. Novel oxorhenium and oxotechnetium complexes from an aminothiol[NS]/thiol[S] mixed-ligand system.
Bouziotis P; Pirmettis I; Pelecanou M; Raptopoulou CP; Terzis A; Papadopoulos M; Chiotellis E
Chemistry; 2001 Sep; 7(17):3671-80. PubMed ID: 11575768
[TBL] [Abstract][Full Text] [Related]
32. Curcumin as the OO bidentate ligand in "2 + 1" complexes with the [M(CO)3]+ (M = Re, 99mTc) tricarbonyl core for radiodiagnostic applications.
Sagnou M; Benaki D; Triantis C; Tsotakos T; Psycharis V; Raptopoulou CP; Pirmettis I; Papadopoulos M; Pelecanou M
Inorg Chem; 2011 Feb; 50(4):1295-303. PubMed ID: 21250638
[TBL] [Abstract][Full Text] [Related]
33. Chemical and biological characterization of technetium(I) and Rhenium(I) tricarbonyl complexes with dithioether ligands serving as linkers for coupling the Tc(CO)(3) and Re(CO)(3) moieties to biologically active molecules.
Pietzsch HJ; Gupta A; Reisgys M; Drews A; Seifert S; Syhre R; Spies H; Alberto R; Abram U; Schubiger PA; Johannsen B
Bioconjug Chem; 2000; 11(3):414-24. PubMed ID: 10821659
[TBL] [Abstract][Full Text] [Related]
34. Microwave-assisted synthesis of organometallic complexes of ⁹⁹mTc(CO)₃ and Re(CO)₃: its application to radiopharmaceuticals.
Kimura H; Mori D; Harada N; Ono M; Ohmomo Y; Kajimoto T; Kawashima H; Saji H
Chem Pharm Bull (Tokyo); 2012; 60(1):79-85. PubMed ID: 22223378
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the best N(3-) donors in preparation of [M(N)(PNP)]-based (M=(99m)Tc-; (188)Re) target-specific radiopharmaceuticals: Comparison among succinic dihydrazide (SDH), N-methyl-S-methyl dithiocarbazate (HDTCZ) and PEGylated N-methyl-S-methyl dithiocarbazate (HO2C-PEG600-DTCZ).
Carta D; Jentschel C; Thieme S; Salvarese N; Morellato N; Refosco F; Ruzza P; Bergmann R; Pietzsch HJ; Bolzati C
Nucl Med Biol; 2014 Aug; 41(7):570-81. PubMed ID: 24909864
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and characterization of novel oxotechnetium (99Tc and 99mTc) and oxorhenium complexes from the 2,2'-bipyridine (NN)/thiol (S) mixed-ligand system.
Papachristou M; Pirmettis IC; Tsoukalas C; Papagiannopoulou D; Raptopoulou C; Terzis A; Stassinopoulou CI; Chiotellis E; Pelecanou M; Papadopoulos M
Inorg Chem; 2003 Sep; 42(18):5778-84. PubMed ID: 12950229
[TBL] [Abstract][Full Text] [Related]
37. NOTA and NODAGA [
Makris G; Radford LL; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM
Bioconjug Chem; 2018 Dec; 29(12):4040-4049. PubMed ID: 30412382
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic imaging agents for Alzheimer's disease: copper radiopharmaceuticals that target Aβ plaques.
Hickey JL; Lim S; Hayne DJ; Paterson BM; White JM; Villemagne VL; Roselt P; Binns D; Cullinane C; Jeffery CM; Price RI; Barnham KJ; Donnelly PS
J Am Chem Soc; 2013 Oct; 135(43):16120-32. PubMed ID: 24070589
[TBL] [Abstract][Full Text] [Related]
39. A gallium(III) Schiff base-curcumin complex that binds to amyloid-β plaques.
Lange JL; Hayne DJ; Roselt P; McLean CA; White JM; Donnelly PS
J Inorg Biochem; 2016 Sep; 162():274-279. PubMed ID: 26988571
[TBL] [Abstract][Full Text] [Related]
40. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
